Article Details
Retrieved on: 2025-01-15 21:48:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AIM ImmunoTech (AIM) highlighted key clinical, regulatory and corporate milestones achieved over 2024 and outlined its expected upcoming milesto.
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here